TOP TIERMARKET NEWSWIRE

News & sentiment

EYEPOINT INC (EYPT) — News & AI sentiment

EYEPOINT INC (EYPT) news roundup. 4 stories in the past week, 30 over 30 days. Average 30-day sentiment is 34.8/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $52K and 0 sales totalling $0 — net buying of $52K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

4

avg sentiment 39.5/100

30d stories

30

avg sentiment 34.8/100

Insider net (90d)

$52K

1 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

EYPT news in the last 24 hours, 7 days, 30 days and 90 days

How much EYPT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	EYPT stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	4	39.5/100	EYPT headlines →
Last 30 days	30	34.8/100	EYPT headlines →
Last 90 days	99	41.8/100	EYPT headlines →

Latest stories on EYPT

EyePoint Pharmaceuticals (EYPT) Securities Investigation Notice - Levi & Korsinsky

GlobeNewswire33 · bearishgeneral

2d ago

EyePoint downgraded to Hold from Buy at Jones

The Fly34 · bearishanalyst

5d ago

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving EyePoint Pharmaceuticals (EYPT)

GlobeNewswire33 · bearishgeneral

6d ago

EyePoint, Inc. (EYPT) Discusses LUCIA Phase III Topline Results for DURAVYU in Wet Age-Related Macular Degeneration - Slideshow

Seeking Alpha58 · neutralproduct/pr

7d ago

EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals

PR Newswire34 · bearishgeneral

Oct 20

EyePoint downgraded to Hold from Buy at Laidlaw

The Fly34 · bearishanalyst

Oct 20

EyePoint price target lowered to $1 from $5 at RBC Capital

The Fly28 · bearishanalyst

Oct 20

EyePoint downgraded to Neutral from Outperform at Mizuho

The Fly34 · bearishanalyst

Oct 20

RBC Capital cuts EyePoint stock price target on trial miss

Investing.com Analyst Ratings34 · bearishanalyst

Oct 20

Why AZN, VSXY, EYPT Stocks Are Moving Premarket Today

Stocktwits News48 · neutralgeneral

Oct 20

Mizuho downgrades EyePoint stock rating on trial failure

Investing.com Analyst Ratings22 · bearishanalyst

Oct 20

EyePoint downgraded to Underweight from Neutral at JPMorgan

The Fly34 · bearishanalyst

Oct 20

Why Did EYPT, CRWV, EOSE Stocks Tumble To 52-Week Lows Today?

Stocktwits News34 · bearishgeneral

Oct 20

EyePoint Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into EyePoint Pharmaceuticals (EYPT)

PR Newswire22 · bearishgeneral

Oct 19

EYPT Stock Layoffs: What to Know About the Latest EyePoint Job Cuts

Barchart34 · bearishgeneral

Oct 19

EyePoint: Stock Takes Shellacking On Second Pivotal Eye Disease Study Miss

Seeking Alpha12 · bearishearnings

Oct 19

Chardan puts EyePoint target under review after trial miss

The Fly34 · bearishanalyst

Oct 19

EyePoint, Inc. (EYPT) Discusses LUCIA Phase III Topline Results for DURAVYU in Wet Age-Related Macular Degeneration Prepared Remarks Transcript

Seeking Alpha58 · neutralproduct/pr

Oct 19

EyePoint downgraded to Neutral from Buy at Guggenheim

The Fly34 · bearishanalyst

Oct 19

Jefferies downgrades Eyepoint stock rating on trial miss

Investing.com Analyst Ratings31 · bearishanalyst

Oct 19

EyePoint downgraded to Hold from Buy at Jefferies

The Fly34 · bearishanalyst

Oct 19

EyePoint price target lowered to $4 from $17 at Citi

The Fly22 · bearishanalyst

Oct 19

EyePoint crashes as pivotal wet AMD trial fails, prompting 53% workforce cut

Investing.com Markets12 · bearishearnings

Oct 19

EyePoint plunges after late-stage trial setback for lead drug against Eylea

Seeking Alpha22 · bearishearnings

Oct 19

Why is EyePoint stock collapsing today?

Investing.com Markets22 · bearishgeneral

Oct 19

Open EYPT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →